Preferred Label : tenoxicam;

CISMeF synonym : Apo-Tenoxicam; Novo-Tenoxicam; apotex brand of tenoxicam; artriunic; mobiflex; novag brand of tenoxicam; novopharm brand of tenoxicam; reutenox; ro 12-0068; roche brand of tenoxicam; solvay brand of tenoxicam;

MeSH synonym : 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide;

MeSH hyponym : Ro-12-0068; Tilcotil;

MeSH Related Number : 59804-37-4 (tenoxicam);

Registry Number MeSH : 59804-37-4;

Is substance : O;

UNII : Z1R9N0A399;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_2608636/fr/tilcotil
http://www.has-sante.fr/portail/jcms/c_1332056/tilcotil
http://www.has-sante.fr/portail/jcms/c_399203/tilcotil-20-mg-comprimes-pellicules-secables-boite-de-15-tilcotil-20-mg-lyophilisat-et-solution-pour-usage-parenteral-im-boite-de-2
2016
false
France
French
evaluation of the transparency committee
tenoxicam
administration, oral
insurance, health, reimbursement
tenoxicam
anti-inflammatory agents, non-steroidal
acute disease
adolescent
adult
arthritis, rheumatoid
spondylitis, ankylosing
reiter syndrome
arthritis, reactive
osteoarthritis
arthritis, psoriatic
periarthritis
bursitis
tendinopathy
low back pain
cyclooxygenase inhibitors
treatment outcome
risk assessment
radiculopathy
neuralgia
piroxicam

---
http://www.lecrat.eu/?s=Etat+des+connaissances+sur+le+tenoxicam
2013
France
French
drug information
teratogens
tenoxicam
pregnancy
fetus
tenoxicam
Product containing tenoxicam (medicinal product)
anti-inflammatory agents, non-steroidal
piroxicam

---
http://www.lecrat.eu/?s=Tenoxicam
2013
France
French
pregnancy
anti-inflammatory agents, non-steroidal
piroxicam
tenoxicam
tenoxicam
drug information

---
http://www.cochrane.org/fr/CD007591
2010
false
true
false
United Kingdom
France
piroxicam
treatment outcome
review of literature
french abstract
tenoxicam
adult
pain, postoperative

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.